TRACK-FA is now closed for recruitment

In August 2023, we finished assessing all participants for their first (baseline) study visit. Currently, we are assessing TRACK-FA participants who are returning for their second (12 month) and third (24 month) study visits.

Click here to get in touch

What will your participation in the study involve?

• Screening assessments to determine your eligibility
• Undertaking neurological clinical rating scales (FA participants only)
• Questionnaires to assess cognition, mood and speech
• Providing a blood sample
• Magnetic resonance imaging (MRI) of your brain and spinal cord

Inclusion criteria (partial) FA participants:

• Age ≥5 years with genetically confirmed diagnosis of FA
• GAA repeat expansion >55 in length on both alleles of the FXN gene or GAA repeat expansion on one allele and another mutation type on the other allele
  (e.g., point mutation, gene deletion)
• Age of disease onset ≤25 years
• Disease duration ≤25 years

Inclusion criteria control participants:

• Age ≥5 years
• Able to provide written informed consent

Exclusion criteria (partial) FA and control:

• MRI contraindications such as pacemaker, other metallic surgical implants, metallic braces
• Pregnancy
• Other ongoing medical conditions, including psychiatric and neurological diagnoses (speak with the site investigator)